$RVV update: Just dropped on Dec 15 – their Bucillamine nerve agent countermeasure study with Canada's DRDC is wrapping up, with final results expected in Jan 2026. Huge potential for stockpiling deals if it pans out. Still grinding on psychedelics too 🌿🧠 Who's holding strong into the new year?
#RVV #Biotech #Psychedelics 🚀